Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma

Fig. 1

Immunohistochemical results. a Endometrial stromal Tumors (hematoxylin and eosin stains, magnification 200). b Cellular leiomyomas (hematoxylin and eosin stains, magnification ×200). c Endometrial stromal tumors showing strong positive results for IFITM1. d Cellular leiomyomas showing a negative or weak expression of IFITM1. e Endometrial stromal tumors exhibiting a positive expression of CD10. f Cellular leiomyomas exhibiting a weekly CD10 positivity. g Endometrial stromal tumors demonstrating SMA reactivity. h Cellular leiomyomas showing strong positive results for SMA. i Endometrial stromal tumors showing a negative or weak expression of h-caldesmon. j Cellular leiomyomas demonstrating strong positive results for h-caldesmon

Back to article page